BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 7692200)

  • 1. De-novo expression of CD44 and survival in gastric cancer.
    Mayer B; Jauch KW; Günthert U; Figdor CG; Schildberg FW; Funke I; Johnson JP
    Lancet; 1993 Oct; 342(8878):1019-22. PubMed ID: 7692200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of the human metastasis adhesion molecule CD44V in normal and carcinomatous stomach mucosa of Chinese subjects.
    Harn HJ; Ho LI; Chang JY; Wu CW; Jiang SY; Lee HS; Lee WH
    Cancer; 1995 Mar; 75(5):1065-71. PubMed ID: 7531611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD44 variant exon epitopes in primary breast cancer and length of survival.
    Kaufmann M; Heider KH; Sinn HP; von Minckwitz G; Ponta H; Herrlich P
    Lancet; 1995 Mar; 345(8950):615-9. PubMed ID: 7534855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of CD44 and its clinical implication in diffuse-type and intestinal-type gastric adenocarcinomas.
    Hong RL; Lee WJ; Shun CT; Chu JS; Chen YC
    Oncology; 1995; 52(4):334-9. PubMed ID: 7539903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of c-erbB-2 protein in gastric cancer. Its correlation with long-term survival of patients.
    Uchino S; Tsuda H; Maruyama K; Kinoshita T; Sasako M; Saito T; Kobayashi M; Hirohashi S
    Cancer; 1993 Dec; 72(11):3179-84. PubMed ID: 7902202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of CD44 splice variants in intestinal- and diffuse-type human gastric carcinomas and normal gastric mucosa.
    Heider KH; Dämmrich J; Skroch-Angel P; Müller-Hermelink HK; Vollmers HP; Herrlich P; Ponta H
    Cancer Res; 1993 Sep; 53(18):4197-203. PubMed ID: 7689929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of cell adhesion molecule CD44 in gastric adenocarcinoma and its prognostic importance.
    Ghaffarzadehgan K; Jafarzadeh M; Raziee HR; Sima HR; Esmaili-Shandiz E; Hosseinnezhad H; Taghizadeh-Kermani A; Moaven O; Bahrani M
    World J Gastroenterol; 2008 Nov; 14(41):6376-81. PubMed ID: 19009655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.
    Guo J; Zu G; Zhou T; Xing J; Wang Z
    Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation of the claudin‑3 promoter predicts the prognosis of advanced gastric adenocarcinoma.
    Zhang Z; Yu W; Chen S; Chen Y; Chen L; Zhang S
    Oncol Rep; 2018 Jul; 40(1):49-60. PubMed ID: 29749528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of hyaluronan receptors CD44 and RHAMM in stomach cancers: relevance with tumor progression.
    Li H; Guo L; Li JW; Liu N; Qi R; Liu J
    Int J Oncol; 2000 Nov; 17(5):927-32. PubMed ID: 11029494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of epidermal growth factor receptor and CD44 splicing variants sharing exons 6 and 9 on gastric and esophageal carcinomas: a two-color flow-cytometric analysis.
    Koyama S; Maruyama T; Adachi S
    J Cancer Res Clin Oncol; 1999; 125(1):47-54. PubMed ID: 10037277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of Reg IV gene and its encoding product in gastric carcinogenesis.
    Zheng HC; Xu XY; Yu M; Takahashi H; Masuda S; Takano Y
    Hum Pathol; 2010 Jan; 41(1):59-69. PubMed ID: 19740514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of leucine-rich-repeat-containing G-protein-coupled receptor 5, an intestinal stem cell marker, in gastric carcinomas.
    Jang BG; Lee BL; Kim WH
    Gastric Cancer; 2016 Jul; 19(3):767-77. PubMed ID: 26386561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the cell adhesion molecule CD44 in gastric adenocarcinomas.
    Washington K; Gottfried MR; Telen MJ
    Hum Pathol; 1994 Oct; 25(10):1043-9. PubMed ID: 7523275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of ADAM17 expression in patients with gastric cancer who underwent curative gastrectomy.
    Aydin D; Bilici A; Yavuzer D; Kefeli U; Tan A; Ercelep O; Mert A; Yuksel S; Ozcelik M; Isik D; Surmeli H; Odabasi H; Aliustaoglu M
    Clin Transl Oncol; 2015 Aug; 17(8):604-11. PubMed ID: 25786367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD44V6 in gastric carcinoma: a marker of tumor progression.
    Xin Y; Grace A; Gallagher MM; Curran BT; Leader MB; Kay EW
    Appl Immunohistochem Mol Morphol; 2001 Jun; 9(2):138-42. PubMed ID: 11396631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
    Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
    J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The fibroblast growth factor receptor-4 Arg388 allele is associated with gastric cancer progression.
    Ye Y; Shi Y; Zhou Y; Du C; Wang C; Zhan H; Zheng B; Cao X; Sun MH; Fu H
    Ann Surg Oncol; 2010 Dec; 17(12):3354-61. PubMed ID: 20844967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of immunohistochemistry and RT-PCR for detection of CD44v-expression, a new prognostic factor in human breast cancer.
    Dall P; Heider KH; Sinn HP; Skroch-Angel P; Adolf G; Kaufmann M; Herrlich P; Ponta H
    Int J Cancer; 1995 Feb; 60(4):471-7. PubMed ID: 7530237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of CD44 containing variant exon 9 (CD44v9) in gastric adenomas and adenocarcinomas: relation to the proliferation and progression.
    Yasui W; Kudo Y; Naka K; Fujimoto J; Ue T; Yokozaki H; Tahara E
    Int J Oncol; 1998 Jun; 12(6):1253-8. PubMed ID: 9592182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.